196 related articles for article (PubMed ID: 34730214)
21. Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease.
Helal I; Al-Rowaie F; Abderrahim E; Kheder A
Saudi J Kidney Dis Transpl; 2017; 28(2):253-260. PubMed ID: 28352004
[TBL] [Abstract][Full Text] [Related]
22. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
Tkachenko O; Helal I; Shchekochikhin D; Schrier RW
Curr Hypertens Rev; 2013 Feb; 9(1):12-20. PubMed ID: 23971639
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.
Grübler MR; Kienreich K; Gaksch M; Verheyen N; Hartaigh BÓ; Fahrleitner-Pammer A; März W; Schmid J; Oberreither EM; Wetzel J; Catena C; Sechi LA; Pieske B; Tomaschitz A; Pilz S
Medicine (Baltimore); 2016 Feb; 95(8):e2794. PubMed ID: 26937909
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease.
Schrier RW; McFann KK; Johnson AM
Kidney Int; 2003 Feb; 63(2):678-85. PubMed ID: 12631134
[TBL] [Abstract][Full Text] [Related]
25. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
26. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
Chapman AB
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1197-204. PubMed ID: 18579674
[TBL] [Abstract][Full Text] [Related]
27. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
Ramunni A; Saracino A; Esposito T; Saliani MT; Coratelli P
Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
[TBL] [Abstract][Full Text] [Related]
28. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
29. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
[TBL] [Abstract][Full Text] [Related]
30. Blood pressure response to exercise in unaffected relatives of autosomal dominant polycystic kidney disease patients: an observational study.
Yenigun EC; Turgut D; Cevher SK; Yucel C; Aypak C; Dede F
Int Urol Nephrol; 2023 Sep; 55(9):2313-2319. PubMed ID: 36872421
[TBL] [Abstract][Full Text] [Related]
31. Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease.
Merta M; Reiterová J; Rysavá R; Tesar V; Závada J; Jáchymová M; Zima T
Physiol Res; 2003; 52(4):433-7. PubMed ID: 12899655
[TBL] [Abstract][Full Text] [Related]
32. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
[TBL] [Abstract][Full Text] [Related]
33. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
[TBL] [Abstract][Full Text] [Related]
34. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
Chapman AB; Johnson A; Gabow PA; Schrier RW
N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
[TBL] [Abstract][Full Text] [Related]
35. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman AB; Johnson AM; Rainguet S; Hossack K; Gabow P; Schrier RW
J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
[TBL] [Abstract][Full Text] [Related]
37. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
38. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
40. Renal artery occlusion in autosomal dominant polycystic kidney disease.
Sánchez M; Enríquez R; Sirvent AE; Millan I; de la Iglesia P; Amorós F
Ren Fail; 2014 Aug; 36(7):1142-4. PubMed ID: 24827072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
